- GW806742X
-
- $40.00
-
2026-07-27
- CAS:579515-63-2
- Purity: 99.07%
- Supply Ability: 10g
- GW806742X
-
- $40.00
-
2026-07-27
- CAS:579515-63-2
- Purity: 99.07%
- Supply Ability: 10g
|
| | GW806742X Basic information |
| Product Name: | GW806742X | | Synonyms: | GW806742X;CS-2659;GW806742X;GW-806742X;GW 806742X;1-[4-[methyl-[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea;GW806742X ≥95%;Benzenesulfonamide, 3-[[4-[methyl[4-[[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]amino]phenyl]amino]-2-pyrimidinyl]amino]-;GW806742X >=98% (HPLC);3-((4-(Methyl(4-(3-(4-(trifluoromethoxy)phenyl)ureido)phenyl)amino)pyrimidin-2-yl)amino)benzenesulfonamide | | CAS: | 579515-63-2 | | MF: | C25H22F3N7O4S | | MW: | 573.55 | | EINECS: | | | Product Categories: | | | Mol File: | 579515-63-2.mol |  |
| | GW806742X Chemical Properties |
| density | 1.524±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:100.0(Max Conc. mg/mL);174.35(Max Conc. mM) | | form | Solid | | pka | 10.09±0.60(Predicted) | | color | White to off-white | | InChIKey | SNRUTMWCDZHKKM-UHFFFAOYSA-N | | SMILES | CN(C1=NC(NC2=CC(S(=O)(N)=O)=CC=C2)=NC=C1)C3=CC=C(NC(NC4=CC=C(OC(F)(F)F)C=C4)=O)C=C3 |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | GW806742X Usage And Synthesis |
| Uses | GW806742X, an ATP mimetic and a potent MLKL (Mixed Lineage Kinase Domain-Like protein) inhibitor, binds the MLKL pseudokinase domain with a Kd of 9.3 μM. GW806742X has activity against VEGFR2 (IC50=2 nM). GW806742X retards MLKL membrane translocation and inhibits necroptosis[1][2]. | | Biological Activity | GW806742X, an ATP mimetic, is a potent MLKL inhibitor that binds the MLKL pseudokinase domain with a Kd of 9.3μM. It has anti-VEGFR2 activity (IC50=2 nM). It delays MLKL membrane translocation and inhibits necrosis. | | in vitro | GW806742X (0.1-10000 nM) inhibits necroptotic death of wild-type mouse dermal fibroblasts (MDFs) stimulated with TSQ (1 ng/mL TNF, 500 nM compound A (Smac mimetic), 10 μM Q-VD -OPh) in a dose-dependent manner. GW806742X shows inhibition of VEGF induced proliferation of HUVECs with an IC50 of 5 nM. | | target | | MLKL 9.3 μM (Kd) | VEGFR2 2 nM (IC 50 < /sub> ) | | | IC 50 | MLKL: 9.3 μM (Kd); VEGFR2: 2 nM (IC50) | | References | [1] Hildebrand JM, et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15072-7. DOI:10.1073/pnas.1408987111
[2] Sammond DM, et al. Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase. Bioorg Med Chem Lett. 2005;15(15):3519-3523. DOI:10.1016/j.bmcl.2005.05.096 |
| | GW806742X Preparation Products And Raw materials |
|